AS Baker

Guidelines on oral anticoagulation: third edition

Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

DOES A SINGLE BOLUS DOSE OF TRANEXAMIC ACID REDUCE BLOOD LOSS AND TRANSFUSION REQUIREMENTS DURING HIP FRACTURE SURGERY? A PROSPECTIVE RANDOMEZED DOUBLE BLIND STUDY IN 67 PATIENTS

Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

Antithrombotic Therapy for Venous Thromboembolic Disease

Pharmacology and Management of the Vitamin K Antagonists

A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis

Interactions between the microbiota, immune and nervous systems in health and disease

Early Complications of Primary Total Hip Replacement Performed with a Two-Incision Minimally Invasive Technique

Perioperative Management of Antithrombotic Therapy

Embolic strokes of undetermined source: the case for a new clinical construct

Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy

Oral Anticoagulant Therapy

Emergency Hospitalizations for Adverse Drug Events in Older Americans

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis

Interaction between microbiota and immunity in health and disease

Prevention of VTE in Nonsurgical Patients

What Is the Male-to-Female Ratio in Autism Spectrum Disorder? A Systematic Review and Meta-Analysis

Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty

Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

Thromboprophylaxis and death after total hip replacement

Prevention of VTE in Nonorthopedic Surgical Patients

Oral Anticoagulants

Prevention of Venous Thromboembolism

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

The operation of the century: total hip replacement

The Central Nervous System and the Gut Microbiome

Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

Obesity is a Major Risk Factor for Prosthetic Infection after Primary Hip Arthroplasty

Prevention of Venous Thromboembolism

The Pharmacology and Management of the Vitamin K Antagonists

Antithrombotic Therapy for Venous Thromboembolic Disease

Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring

Diversity, stability and resilience of the human gut microbiota

Guidelines for the Prevention of Intravascular Catheter-related Infections

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

Hemorrhagic Complications of Anticoagulant Treatment

Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta‐analysis

The pros, cons, and many unknowns of probiotics

Early life exposures

Guidelines for the Early Management of Adults With Ischemic Stroke

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

THROMBOPROPHYLAXIS AND DEATH AFTER TOTAL HIP REPLACEMENT

Minidose Warfarin and Failure to Prevent Deep Vein Thrombosis After Joint Replacement Surgery Despite Inhibiting the Postoperative Rise in Plasminogen Activator Inhibitor Activity

Antenatal interventions for reducing weight in obese women for improving pregnancy outcome

Annual Research Review: The role of the environment in the developmental psychopathology of autism spectrum condition

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

Guidelines for the Primary Prevention of Stroke

Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.

Bone bleeding during total hip arthroplasty after administration of tranexamic acid

A Meta-analysis of Methods to Prevent Venous Thromboembolism Following Total Hip Replacement

Guidelines for Adult Stroke Rehabilitation and Recovery

Low-Molecular-Weight Heparins

Development and validation of a predictive model for chemotherapy-associated thrombosis

Prosthetic Joint Infection

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack

Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis

Maternal Metabolic Conditions and Risk for Autism and Other Neurodevelopmental Disorders

Abductor function after total hip replacement. An electromyographic and clinical review

Efficacy of fixed minidose warfarin prophylaxis in total hip replacement.

Control of bleeding in cemented arthroplasty